Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pehuaxihaimatai vs Epoetin for Anemia in Dialysis-Dependent CKD
CTR20190209Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- May 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pehuaxihaimapeptide in anaemia, sponsored by Hengrui Therapeutics. Started May 2019; status: completed.
02
Drugs
pehuaxihaimapeptide
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20190209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190209.